| A comparative analysis of the endocannabinoid system in the retina of mice, tree shrews, and monkeys J Bouskila, P Javadi, L Elkrief, C Casanova, JF Bouchard, M Ptito Neural Plasticity 2016, 2016 | 24 | 2016 |
| Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene MP Boks, Y He, CD Schubart, W van Gastel, L Elkrief, G Huguet, ... Brain, behavior, and immunity 88, 573-581, 2020 | 20 | 2020 |
| Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens R Kucera, J Bouskila, L Elkrief, A Fink-Jensen, R Palmour, JF Bouchard, ... Scientific reports 8 (1), 8689, 2018 | 18 | 2018 |
| Childhood maltreatment mediates the effect of the genetic background on psychosis risk in young adults M Marchi, L Elkrief, A Alkema, W van Gastel, CD Schubart, KR van Eijk, ... Translational psychiatry 12 (1), 219, 2022 | 11 | 2022 |
| Independent contribution of polygenic risk for schizophrenia and cannabis use in predicting psychotic-like experiences in young adulthood: testing gene× environment moderation … L Elkrief, B Lin, M Marchi, MH Afzali, T Banaschewski, ALW Bokde, ... Psychological medicine 53 (5), 1759-1769, 2023 | 8 | 2023 |
| Assessing the current state of medical education on cannabis in Canada: Preliminary findings from Quebec L Elkrief, J Belliveau, T D’Ignazio, P Simard, D Jutras-Aswad Paediatrics & Child Health 25 (Supplement_1), S29-S33, 2020 | 8 | 2020 |
| Prolonged intermittent theta burst stimulation in the treatment of major depressive disorder: A case series M Richard, C Noiseux, VD Jodoin, DM Blumberger, J Sheen, F Mansouri, ... Psychiatry Research 315, 114709, 2022 | 6 | 2022 |
| Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report L Elkrief, O Payette, JN Foucault, C Longpré-Poirier, M Richard, ... Frontiers in psychiatry 13, 986378, 2022 | 5 | 2022 |
| Endocannabinoid gene× gene interaction association to alcohol use disorder in two adolescent cohorts L Elkrief, S Spinney, DE Vosberg, T Banaschewski, ALW Bokde, ... Frontiers in Psychiatry 12, 645746, 2021 | 5 | 2021 |
| Intravenous ketamine for treatment-resistant depression patients who have failed to respond to transcranial magnetic stimulation: A case series O Payette, P Lespérance, VD Jodoin, C Longpré-Poirier, L Elkrief, ... Journal of Affective Disorders 333, 18-20, 2023 | 3 | 2023 |
| State of the science: The hierarchical taxonomy of Psychopathology (HiTOP) DC Cicero, CJ Ruggero, CE Balling, AR Bottera, S Cheli, L Elkrief, ... Behavior Therapy, 2024 | 2 | 2024 |
| Differential effect of cannabis use on opioid agonist treatment outcomes: exploratory analyses from the OPTIMA study L Elkrief, G Bastien, C McAnulty, H Bakouni, FO Hébert, ME Socias, ... Journal of Substance Use and Addiction Treatment 149, 209031, 2023 | 2 | 2023 |
| Effects of prenatal alcohol exposure on the visual system of monkeys measured at different stages of development V Harrar, L Elkrief, J Bouskila, R Kucera, A Fink-Jensen, JF Bouchard, ... Investigative ophthalmology & visual science 58 (14), 6282-6291, 2017 | 2 | 2017 |
| Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized … G Bastien, A Abboud, C McAnulty, L Elkrief, O Ledjiar, ME Socias, ... Journal of Dual Diagnosis, 1-12, 2024 | | 2024 |
| Associations Between Opioid Agonist Treatment and Withdrawal Symptoms: Exploratory Analyses from the OPTIMA Study H Bakouni, L Elkrief, S Bijou-Coulon, ME Socias, B Le Foll, R Lim, ... Canadian Journal of Addiction 15 (1), 6-15, 2024 | | 2024 |
| Understanding the shared genetic risk for psychosis and substance use disorders: a study of genetic markers of endogenous and exogenous cannabinoid-related Risk L Elkrief | | 2021 |
